Listen
Reason for request
Inclusion of the list of medicines reimbursed by National Insurance and approved for use by hospitals. .
-
Clinical Benefit
| Substantial |
The actual benefit of these drugs is substantial. |
Clinical Added Value
| minor |
INOVELON offers a minor (level IV) improvement in actual benefit in the therapeutic management of patients aged 4 and over with Lennox-Gastaut syndrome that is resistant to first-line treatments. |
English version
Contact Us
Évaluation des médicaments
Français